Gadofosveset-enhanced magnetic resonance angiography as a means of evaluating pulmonary arteriovenous malformation: a case report

详细信息	查看全文 | 推荐本文 |

• 作者：Josephine Pressacco ; ^{josephine.pressacco@icm-mhi.org} ; Konstantin Papas
• 关键词：Blood pool agents ; Gadofosveset ; Ablavar ; Pulmonary arterio-venous malformation ; Magnetic resonance imaging ; Magnetic resonance angiograpy
• 刊名：Magnetic Resonance Imaging
• 出版年：2012
• 期刊代码：188_0730725x
• 类别：med
• 出版时间：July, 2012
• 卷：30
• 期：6
• 页码：886-888
• 文件大小：417 K

摘要

This case report is a unique presentation of a new potential indication for Gadofosvest (Ablavar), a blood pool contrast agent for magnetic resonance angiography (MRA). Ablavar is an excellent MRA contrast agent because it provides optimal contrast opacification of both the arterial and venous system, unlike the conventional extracellular agents that are used for arterial imaging only. The present case report demonstrates the ability of Ablavar to demonstrate pulmonary arteriovenous malformation (AVM), showing both its arterial feeders as well as its venous drainage tract.